Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study ...

Explore AI-aligned degrees with real job market advantages—combining tech skills, human insight, and industry relevance to ...

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...